Hardip Thakerar

Hardip Thakerar is a seasoned professional in therapy development with extensive experience in the cardiovascular sector. Currently serving as Global VP Therapy Development at Pi-Cardia since November 2020, Hardip previously held the position of VP Clinical/Therapy Development at 4tech cardio from February 2016 to November 2020. Prior to that, Hardip was Vice President of Therapy Development at Twelve Inc, where notable work led to the acquisition of the company's mitral valve replacement technology by Medtronic in 2015. Hardip's career also includes a role as Global Director of Structural Heart at Boston Scientific from September 2012 to July 2015.